Lenalidomide in High-risk MDS and AML With Del(5q) or Monosomy 5

NCT00761449 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

28

Enrollment

NETWORK

Sponsor class

Conditions

MDS
AML

Interventions

DRUG: lenalidomide

Sponsor

Nordic MDS Group